Home › Trials › Liver & pancreas

Liver cancer

A Phase IIIb, randomized, multicenter, open-label trial of evaluating safety and efficacy with treatment of Atezolizumab and Bevacizumab as a novel alternative treatment method to TACE in intermediate stage liver cancer patients.

Who can joinAdults

Age18+ years

Kind of studyPhase 3: compared with usual treatment

What it testsA medicine and surgery or a procedure and a test

The full list of who can and cannot join is on the registry. Ask the trial team, or write to us and we will explain it in simple words.

Contact hospital

The registry names this hospital as the trial's main contact. Ask them which hospitals are taking patients.

Tata Memorial CentreMumbai, MaharashtraDirections ↗

Registry summary (technical)

The ABC-HCC Trial:A Phase IIIb, randomized, multicenter, open-label trial ofAtezolizumab plus Bevacizumabversus transarterial Chemoembolization (TACE)in intermediate-stage HepatoCellular Carcinoma - The ABC-HCC Trial

Sponsor: Frankfurter Institut für Klinische Krebsforschung IKF GmbH
CTRI/2024/11/077188 on CTRI, India's trial registry
Source: Clinical Trials Registry – India (CTRI), via WHO ICTRP, data of 12 Oct 2026
Last updated on the registry 14 Sep 2026 · read by us 5 Nov 2026

Need help reaching the trial team? Write to us.

Tell us the city, the type of cancer and the trial number if you have one. We reply in simple words within 3 working days.

ट्रायल टीम से जुड़ने में मदद चाहिए? हमें ईमेल करें।

ట్రయల్ టీమ్‌ను సంప్రదించడానికి సహాయం కావాలా? మాకు ఈమెయిల్ చేయండి.

சோதனைக் குழுவை தொடர்பு கொள்ள உதவி வேண்டுமா? எங்களுக்கு மின்னஞ்சல் செய்யுங்கள்.